The Wilcoxon signed-rank test showed that the immunostaining CYP24A1 distribution in uveal melanoma and uveal melanocytes, uveal melanoma and other uveal cells significantly differ from each other (p < 0.001) (Fig. 2F). This evidence concerns the gene CYP24A1 and uveal melanoma.